Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First patient recruited in phase II study of preterm labor drug OBE-001

June 25, 2015

Bayer Schering Pharma describes GnRH receptor antagonists

June 23, 2015

Final data confirm benefit of imeglimin in phase IIb diabetes trial

June 23, 2015

Once-weekly LAPSInsulin Combo shows better glycemic control, reduced side effects

June 19, 2015

Radius Health reports results from phase III trials of abaloparatide in osteoporosis

June 18, 2015

Chong Kung Dang presents GPR119 agonists

June 18, 2015

Lipocine completes food effect study of oral testosterone LPCN-1021

June 17, 2015

PhaseBio presents data on diabetes candidates PE-0139 and PB-1023

June 17, 2015

Chiasma files NDA for oral octreotide in acromegaly

June 16, 2015

Genzyme starts phase I/II trial of olipudase alfa in children with Niemann-Pick disease

June 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...